4//SEC Filing
Trachtenberg Eric 4
Accession 0001415889-22-010882
CIK 0001479419other
Filed
Oct 27, 8:00 PM ET
Accepted
Oct 28, 4:15 PM ET
Size
5.7 KB
Accession
0001415889-22-010882
Insider Transaction Report
Form 4
Trachtenberg Eric
General Counsel and Secretary
Transactions
- Sale
Common Stock
2022-10-26$6.52/sh−194$1,265→ 2,030 total
Footnotes (4)
- [F1]This sale was made pursuant to a 10b5-1 trading plan to cover tax withholding obligations in connection with the vesting and settlement of the Reporting Person's performance-based restricted stock units ("RSUs") granted on June 25, 2020.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.51 to $6.62, inclusive. The Reporting Person undertakes to provide to Kala Pharmaceuticals, Inc., any security holder of Kala Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- [F3]Includes 302 unvested RSUs.
- [F4]The number of shares of common stock reported on this Form 4 reflects a 1-for-50 reverse stock split effected by the Issuer on October 20, 2022.
Documents
Issuer
Kala Pharmaceuticals, Inc.
CIK 0001479419
Entity typeother
Related Parties
1- filerCIK 0001646300
Filing Metadata
- Form type
- 4
- Filed
- Oct 27, 8:00 PM ET
- Accepted
- Oct 28, 4:15 PM ET
- Size
- 5.7 KB